An interventional study of Sertraline in Depression, sponsored by University Hospital Freiburg. Completed at 1 site in Germany. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2007-06-04.
Sponsored by University Hospital Freiburg · Not applicable, Interventional, and Treatment
12 normal healthy controls will be treated with 50 mg sertraline once daily for three weeks. Early amplitudes of visually evoked potentials will be examined at day 0, 10 and 21 and statistically compared. This study aims to examine a putative modulation of synaptic transmission and plasticity by an antidepressant and is part of a series of studies in healthy individuals and depressed patients.
8,059 studies on the registry are indexed under Depression; 1,643 are open to participants now.
This study's enrollment of 12 is below the median of 84 across 6,722 interventional studies indexed under Depression.
Browse Depression studies →University Hospital Freiburg is the lead sponsor of 91 studies on the registry; 18 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Amplitudes and latencies of early visually evoked potentials.
This study is completed, as verified in May 2007. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital Freiburg